Skip to content

DESMOND (Diabetes Education and Self Management for Ongoing and Newly Diagnosed): a randomised controlled trial of a structured group education programme for people newly diagnosed with type two diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17844016
Enrollment
1000
Registered
2007-05-16
Start date
2004-07-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Self management of type two diabetes Nutritional, Metabolic, Endocrine Diabetes mellitus

Interventions

A programme of six hours of structured group education consisting of two three-hour sessions offered as either one day or two half-days, facilitated by two health care professionals trained to deliver

Sponsors

University Hospitals of Leicester NHS Trust (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Greater than 18 years of age 2. Referred to the study within four weeks of diagnosis of type two diabetes 3. In intervention group, able to attend the intervention within 12 weeks of diagnosis

Exclusion criteria

Exclusion criteria: 1. Are unable to give informed consent 2. Have been recruited to take part, or are already taking part in other research 3. Have severe and enduring mental health problems 4. Are not primarily responsible for their own care 5. Are unable to participate in a group programme 6. Have insufficient understanding of English to participate in the group education

Design outcomes

Primary

MeasureTime frame
Glycaemic control as measured by HbA1c at 12 months.

Secondary

MeasureTime frame
1. Cardiovascular (CV) risk as measured by lipid profile and blood pressure 2. Quality of life indicators, diabetes control, self-care and illness belief perceptions of patients at 12 months

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 5, 2026